Therapeutic effect of the recombinant human epidermal growth factor (rhEGF) in pressure ulcer – CGBIO_ID

home

R & D

Research Info

Cho KH, Kim YJ.

Therapeutic Effect of the Recombinant Human Epidermal Growth Factor (rhEGF) in Pressure Ulcer.

J Korean Acad Rehabil Med 2010; 34(3): 253-8.

NEXT

Epidermal growth factor induces cell death in the absence of overexpressed epidermal growth factor receptor and ErbB2 in various human cancer cell lines.

PREV

Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial

to be updated.